Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women (Q33319315)

25 July 2017

title

Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women (English)

1 reference

25 July 2017

1 reference

Edward R Sauter

1

1 reference

25 July 2017

Wenyi Qin

2

1 reference

25 July 2017

John E Hewett

3

1 reference

25 July 2017

Rachel L Ruhlen

4

1 reference

25 July 2017

John T Flynn

5

1 reference

25 July 2017

George Rottinghaus

6

1 reference

25 July 2017

Yin-Chieh Chen

7

1 reference

25 July 2017

language of work or name

English

0 references

publication date

11 February 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

page(s)

49

1 reference

Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Balancing gastroprotection and cardioprotection with selective cyclo-oxygenase-2 inhibitors: clinical implications

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Gastrointestinal effects of nonsteroidal anti-inflammatory drugs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Transfer of celecoxib into human milk

14 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/1471-2407-8-49

Determination of celecoxib in human plasma using solid-phase extraction and high-performance liquid chromatography

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/1471-2407-8-49

Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/1471-2407-8-49

Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Lack of effect of celecoxib on prostaglandin E2 concentrations in nipple aspirate fluid from women at increased risk of breast cancer.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259321

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

31 October 2018

1 reference

12 December 2020

Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models

1 reference

12 December 2020

Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

12 December 2020

Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-49

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference